Acuta Capital Partners, LLC Aerie Pharmaceuticals Inc Put Options Transaction History

Acuta Capital Partners, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2018 Nov 07, 2018	SELL	$56.15 - $73.9 $3.43 Million - $4.51 Million	-61,000 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$47.85 - $70.45 $2.44 Million - $3.59 Million	51,000 Added 510.0%	61,000 $4.12 Million
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $511,500 - $610,000	10,000 New	10,000 $543,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.